跳至主要内容
临床试验/NCT06800677
NCT06800677进行中(未招募)不适用

Methylated Biomarkers Predictive of Endometrial Cancer Risk

University of Manchester1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年7月31日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
200
试验地点
1
主要终点
Sensitivity, specificity, negative and positive predictive value of single gene methylation classifiers in predicting the presence of endometrial cancer in minimally- and invasive samples

研究概览

简要总结

The goal of this observational study is to identify endometrial cancer risk predictive biomarkers and to optimise the methodology for their detection and quantification in non-invasive samples.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
45 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 45-70 years
  • Attending St Mary's Hospital, Manchester for an elective hysterectomy by any route for either the treatment of endometrial cancer or a benign gynaecological condition
  • Able to consent to participation in the study

排除标准

  • Presence of malignancy asides from endometrial cancer
  • Undergoing elective hysterectomy for suspected ovarian cancer

结局指标

主要结局

Sensitivity, specificity, negative and positive predictive value of single gene methylation classifiers in predicting the presence of endometrial cancer in minimally- and invasive samples

时间窗: 1 day

次要结局

  • Sensitivity, specificity, positive and negative predictive value of a multi-gene methylation classifier for predicting the presence of endometrial cancer(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Kitson

Clinical Lecturer

University of Manchester

研究点 (1)

Loading locations...

相似试验